Tag: Pieris Pharmaceuticals
May 26, 2019
5 Top Weekly NASDAQ Biotech and Pharma Stocks: Sesen Bio Up 40 Percent
Which NASDAQ biotech and pharma stocks were up last week? We examine the top five gainers and what may have... November 7, 2018
Pieris Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
Pieris Pharmaceuticals (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory, cancer and other... September 4, 2018
Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy
Pieris Pharmaceuticals (NASDAQ:PIRS), a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for cancer, respiratory and other diseases, announced...
June 5, 2018
10 Top Immuno-Oncology Companies
One of the most highly anticipated methods to fight cancer is the immuno-oncology (I/O) sector. For investors interested in the... February 14, 2018
Pieris Pharmaceuticals Announces Public Offering of Common Stock
Pieris Pharmaceuticals (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for cancer, respiratory and other... February 9, 2018
Pieris Pharmaceuticals and Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration
Pieris Pharmaceuticals (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for cancer, respiratory and other... December 7, 2017
